Search

everythinglearnresearchcommunity

for

Search:↓

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Dienogest combined with ethinylestradiol is a highly effective birth control that improves menstrual symptoms and has manageable side effects.

Testosterone may slow down wound healing and increase inflammation.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Androgens increase EPO production, finasteride doesn't significantly impact it.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

Alopecia patients have a less active liver monoxygenase system, which can be treated with photochemotherapy and system inducers.

Psychological factors play a significant role in developing alopecia areata.

Spironolactone is more effective than finasteride in treating excessive hair growth in women.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

A vaccine may prevent benign prostatic hyperplasia (BPH).

Hormones significantly influence hair growth, with conditions like hirsutism and patterned hair loss linked to hormone levels; more research is needed for full understanding.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Ovarian drilling surgery is not clearly better than medical treatments for PCOS symptoms.

Blocking androgen activity in newborn rats affects body weight and appetite-related hormones differently in males and females.